Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial
Introduction Neonatal hypoxic-ischaemic encephalopathy (HIE) is an important illness associated with death or cerebral palsy. This study aims to assess the safety and tolerability of the allogenic human multilineage-differentiating stress-enduring cell (Muse cell)-based product (CL2020) cells in new...
Главные авторы: | Akihiro Hirakawa, Masahiko Ando, Masahiro Hayakawa, Nao Matsuyama, Shinobu Shimizu, Kazuto Ueda, Toshihiko Suzuki, Sakiko Suzuki, Ryosuke Miura, Akemi Katayama, Masaaki Mizuno, Yoshiaki Sato |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
BMJ Publishing Group
2022-04-01
|
Серии: | BMJ Open |
Online-ссылка: | https://bmjopen.bmj.com/content/12/4/e057073.full |
Схожие документы
-
Systemic administration of clinical-grade multilineage-differentiating stress-enduring cells ameliorates hypoxic–ischemic brain injury in neonatal rats
по: Kazuto Ueda, и др.
Опубликовано: (2023-09-01) -
Incidence of hypoxic-ischaemic encephalopathy and use of therapeutic hypothermia in Spain
по: Juan Arnaez, и др.
Опубликовано: (2018-07-01) -
Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data
по: Edwards, A, и др.
Опубликовано: (2010) -
Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: a nested substudy of a randomised controlled trial.
по: Rutherford, M, и др.
Опубликовано: (2010) -
THE EXPERIENCE OF USING LOW-TECHNOLOGY HYPOTHERMIA IN THE NEWBORN WITH SEVERE HYPOXIC ISCHAEMIC ENCEPHALOPATHY
по: A. A. Zadvornov, и др.
Опубликовано: (2017-12-01)